26th AMLI ANNUAL MEETING 2013

Saturday, August 10, 2013

7:30 

Continental Breakfast

8:30-8:35  

Opening Remarks
Antony Bakke, Ph.D., AMLI President

Plenary Session I
Inflammation in Health and Disease
Chair: Bruce S. Rabin, Ph.D.

8:35

Definition of Inflammation and Measurement of Markers of Inflammation
Bruce S. Rabin, Ph.D., UPMC Presbyterian, Pittsburgh, Pennsylvania

9:15

Glucocorticoid Modulation of Inflammation and Glucocorticoid Resistance
Thaddeus Pace, Ph.D., Emory University School of Medicine, Emory Winship
Cancer Institute, Atlanta, Georgia

10:00

Break

10:30

Modulation of the Inflammatory Response to Enhance Health
Janice Kiecolt-Glaser, Ph.D., Institute for Behavioral Medicine Research, Ohio State University College of Medicine, Columbus, Ohio

11:15

Panel Discussion

11:45  

Relaxation CD demonstration

12:00-1:30   

Luncheon Seminar hosted by: INOVA Diagnostics, Inc.
 Changing Paradigm in the  Autoimmune Laboratory Through Chemiluminescence Technology
Michael Mahler, Ph.D., INOVA Diagnostics, Inc.; Thomas Alexander,Ph.D., Summa Health System

Plenary Session 2
Complement
Chairs: Patsy Giclas, Ph.D. and Susie Orton, Ph.D.

2:00   

HAE -The Clinical Side of Hereditary Angioedema
Michael M. Frank, M.D., Duke University Medical Center, Durham, North Carolina

2:20   

HAE – The Lab Diagnostic Side of Hereditary Angioedema
Ashley Frazer-Abel, Ph.D., National Jewish Health, Denver, Colorado

2:45  

Complement Dysregulation in aHUS, DDD and C3GN
Richard J. H. Smith, M.D., Iowa City, Iowa

3:30

Mannose Binding Lectin and Cardiovascular Dysfunction
Gregory L. Stahl, Ph.D., Harvard Medical School, Cambridge, Massachusetts

4:15

Diagnosis of Acquired vs. Inherited Complement Deficiencies
Patricia C. Giclas, Ph.D., National Jewish Health, Denver, Colorado

5:00-7:00

Meet the Exhibitors-Poster Session Reception

Sunday, August 11, 2013

7:30 

Continental Breakfast – Committee Meetings – Exhibits Open

Plenary Session 3
Serological Testing for Gastrointestinal Disorders: Past, Present, and Future

Chairs: Evangelos Ntrivalas, M.D., Ph.D. and Ifor Williams, M.D., Ph.D.

8:30

Celiac Disease and the Role of the Clinical Laboratory
Melissa R. Snyder, Ph.D., Mayo Clinic, Rochester, Minnesota

9:30

Promise and Pitfalls of IBD Serologies
Joseph H. Sellin, M.D., Baylor College of Medicine, Houston, Texas

10:30

Break – Exhibits Open

11:00

Immunoassay Methods for the Diagnosis and Management of Food Allergy
Wayne Shreffler, M.D., Massachusetts General Hospital, Boston, Massachusetts

12:00-1:30

Luncheon Seminar hosted by: Thermo Fisher Scientific
Anna Nowak-Węgrzyn, MD, Mount Sinai School of Medicine, New
York, NY

2:00 – 3:00   

Erwin Neter Memorial Lecture
What Can the Laboratory Contribute to the Management of the Monoclonal Gammopathies?

Robert Kyle, M.D., Mayo Clinic, Rochester, Minnesota

3:00-3:30  

Abstract Award Presentations

3:30-4:00

MLI Business Meeting

4:00-6:00

Meet the Exhibitors – Poster Session Reception

6:00-9:00

Annual Dinner:  Savannah Harbor tour, dinner and music/dancing
on the Riverboat Georgia Queen. Boarding and cocktails 6-7 at our hotel’s
dock, tour and dinner 7-9.

Monday, August 12, 2013

7:30 

Continental Breakfast – Committee Meetings – Exhibits Open

Plenary Session 4
NK Cells and Interaction with HLA Molecules

Chairs: John Schmitz, Ph.D. and Trivikram Dasu, Ph.D.

8:30

MHC Dependence in NK-mediated Immune Function
Wayne M. Yokoyama, M.D., Washington University School of Medicine, St. Louis, Missouri

9:15 

NK Cells and Their Receptors in Cancer and Transplantation
Jeffrey S. Miller, M.D., Masonic Cancer Research Center, Cancer Experimental Therapeutics Initiative, Minneapolis, Minnesota

10:00

Break – Exhibits Open

10:30

Use of NK Cells in Cell-based Therapies
Wing H. Leung, M.D., Ph.D., St. Jude Children’s Research Hospital,
Memphis, Tennessee

11:15

Containing ‘Cytokine-release Syndrome’ during K Cell-mediated Immunotherapy
Subra Malarkannan, Ph.D., Medical College of Wisconsin, Milwaukee, Wisconsin

12:00-1:30  

Luncheon Seminar hosted by: Bio-Rad Laboratories Inc.
 Update on HIV:  New Tests, New Indications, New Algorithms
Bernie Branson, M.D., HIV Laboratory Diagnostics, Centers for Disease       Control and Prevention, Atlanta, Georgia

FREE AFTERNOON

Tuesday, August 13, 2013

7:30 

Continental Breakfast

Plenary Session 5
New Biologics
Chairs: Vijaya Nagabhushanam Knight, M.D., Ph.D. and Roshini Abraham, Ph.D.

8:30

Clinical Applications and Challenges of B-lymphocyte Monitoring in
Patients with ANCA-associated Vasculitis (AAV) Treated with Rituximab

Tobias Peikert, M.D., Mayo Clinic, Rochester, Minnesota

9:05

Overview of New Biologics, Historical Aspects, Antibody Engineering, Immunogenicity of New Biologics
Juan Carlos Almagro, Ph.D., CTI-Boston, Pfizer, Boston, Massachusetts

9:40 

New Paradigms in Immunogenicity Assessment of Biotherapeutics
Vibha Jawa, Ph.D., Amgen, Inc., Woburn, Massachusetts

10:15

Break

10:45

Regulating Immune Responses to Biologics with Tregitopes, A Paradigm-Shifting Solution?
Leslie P. Cousens, Ph.D., EpiVax, Inc., Providence, Rhode Island

11:20  

Biologic Immune Response Modifiers: the Good, the Bad, and the Ugly
Mark Ballow, M.D., Women’s and Children’s Hospital, Buffalo, New York

11:55

Closing Remarks